Complete Filing Data
Xeris Biopharma Holdings, Inc. reported Stockholders Equity of $13.69 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Xeris Biopharma Holdings, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue * | $291.8M | $203.1M | $163.9M | $110.2M | $49.6M | $20.2M |
| Net Income Loss | $554.0K | -$54.8M | -$62.3M | -$94.7M | -$122.7M | -$91.1M |
| Other Comprehensive Income Loss Net Of Tax | -$2.0K | $8.0K | -$37.0K | -$37.0K | ||
| Selling General And Administrative Expense | $182.4M | $163.5M | $146.1M | $137.7M | $125.7M | $73.7M |
| Research And Development Expense | $31.2M | $25.6M | $22.3M | $21.0M | $25.2M | $20.9M |
| Other Nonoperating Income Expense | -$24.3M | -$23.5M | -$19.5M | -$14.1M | -$7.6M | -$7.7M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax | $0.00 | $0.00 | -$2.0K | $7.0K | -$38.0K | -$10.0K |
| Operating Income Loss | $24.9M | -$33.6M | -$44.0M | -$81.9M | -$115.2M | -$83.5M |
| Income Tax Expense Benefit | $0.00 | -$2.3M | -$1.2M | -$1.4M | $0.00 | -$110.0K |
| Comprehensive Income Net Of Tax | $554.0K | -$54.8M | -$62.3M | -$94.7M | -$122.8M | -$91.2M |
| Amortization Of Intangible Assets | $10.8M | $10.8M | $10.8M | $10.8M | $550.0K | $0.00 |
| Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax | $0.00 | $0.00 | $1.0K | $1.0K | -$27.0K | |
| Cost Of Goods And Services Sold |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue * | $74.4M | $71.5M | $60.1M | $54.3M | $48.1M | $40.6M | $48.3M | $38.0M | $33.2M | $29.7M | $25.3M | $22.1M | $11.1M | $8.9M | $8.1M | $9.4M | ||
| Net Income Loss | $621.0K | -$1.9M | -$9.2M | -$15.7M | -$15.0M | -$19.0M | -$12.2M | -$19.8M | -$16.8M | -$21.8M | -$26.2M | -$33.7M | -$26.0M | -$27.5M | -$18.4M | -$16.0M | -$24.1M | -$29.2M |
| Other Comprehensive Income Loss Net Of Tax | -$1.0K | $1.0K | $15.0K | $5.0K | -$11.0K | $28.0K | -$49.0K | -$6.0K | $15.0K | $14.0K | -$35.0K | -$6.0K | -$10.0K | -$16.0K | -$108.0K | $104.0K | $17.0K | |
| Selling General And Administrative Expense | $46.5M | $44.4M | $44.0M | $45.0M | $40.0M | $38.4M | $37.3M | $37.6M | $33.6M | $34.5M | $33.0M | $35.9M | $26.5M | $25.9M | $19.1M | $16.5M | ||
| Research And Development Expense | $7.5M | $8.1M | $7.8M | $5.9M | $5.8M | $7.8M | $5.0M | $6.1M | $4.8M | $6.0M | $3.7M | $6.3M | $5.7M | $5.4M | $4.0M | $3.9M | ||
| Other Nonoperating Income Expense | -$6.1M | -$6.4M | -$6.1M | -$6.2M | -$6.1M | -$4.4M | -$7.6M | -$4.5M | -$3.6M | -$3.4M | -$7.6M | -$5.0M | -$1.7M | -$1.7M | -$1.7M | -$2.3M | ||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax | $0.00 | $0.00 | $0.00 | $15.0K | $5.0K | -$10.0K | $28.0K | -$49.0K | -$6.0K | $16.0K | $14.0K | -$35.0K | -$5.0K | -$12.0K | -$17.0K | -$125.0K | ||
| Operating Income Loss | $6.7M | $4.5M | -$3.1M | -$12.9M | -$8.2M | -$14.2M | -$4.9M | -$16.0M | -$13.3M | -$18.8M | -$18.9M | -$29.1M | -$24.4M | -$25.8M | -$16.7M | -$13.7M | ||
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | -$3.3M | $749.0K | $307.0K | -$338.0K | -$675.0K | $0.00 | -$339.0K | -$339.0K | -$408.0K | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Comprehensive Income Net Of Tax | $620.0K | -$1.9M | -$9.2M | -$15.7M | -$15.0M | -$19.0M | -$12.2M | -$19.9M | -$16.8M | -$21.8M | -$26.2M | -$33.7M | -$26.0M | -$27.5M | -$18.4M | -$16.1M | ||
| Amortization Of Intangible Assets | $2.7M | $2.7M | $2.7M | $2.7M | $2.7M | $2.7M | $2.7M | $2.7M | $2.7M | $2.7M | $2.7M | $2.7M | $0.00 | $0.00 | $0.00 | |||
| Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax | -$1.0K | $1.0K | $0.00 | $0.00 | $1.0K | -$1.0K | $0.00 | $0.00 | $0.00 | -$1.0K | $0.00 | $0.00 | -$1.0K | $2.0K | $1.0K | $17.0K | ||
| Cost Of Goods And Services Sold | $3.2M | $2.8M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $13.7M | -$29.6M | -$6.8M | $45.2M | $95.2M | $33.8M | $14.4M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $115.1M | $75.7M | $71.7M | $126.3M | $67.3M | $37.6M | |
| Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | $0.00 | -$4.4M | -$5.2M | $3.2M | $0.00 | ||
| Cash And Cash Equivalents At Carrying Value | $111.0M | $71.6M | $67.4M | $122.0M | $67.3M | $37.6M | $19.5M |
| Accretion Amortization Of Discounts And Premiums Investments | $0.00 | $747.0K | $1.3M | -$184.0K | -$413.0K | -$84.0K | |
| Retained Earnings Accumulated Deficit | -$671.3M | -$671.9M | -$617.0M | -$554.8M | -$460.1M | -$337.4M | |
| Property Plant And Equipment Net | $4.9M | $5.6M | $6.0M | $5.5M | $6.6M | $6.7M | |
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Other Liabilities Noncurrent | $8.4M | $2.0M | $4.8M | $31.0K | $1.7M | $3.5M | |
| Other Liabilities Current | $4.9M | $1.1M | $1.2M | $2.7M | $2.0M | $322.0K | |
| Other Assets Noncurrent | $5.2M | $5.4M | $4.5M | $4.7M | $829.0K | $232.0K | |
| Liabilities Current | $109.6M | $100.4M | $95.2M | $73.6M | $79.0M | $28.2M | |
| Liabilities And Stockholders Equity | $383.5M | $323.1M | $322.6M | $344.5M | $304.4M | $159.2M | |
| Liabilities | $369.8M | $352.7M | $329.4M | $299.3M | $209.1M | $125.4M | |
| Inventory Net | $68.7M | $48.2M | $38.8M | $24.7M | $18.1M | $8.4M | |
| Common Stock Value | $17.0K | $15.0K | $14.0K | $14.0K | $13.0K | $6.0K | |
| Assets Current | $240.3M | $167.7M | $156.3M | $186.8M | $142.6M | $152.2M | |
| Assets | $383.5M | $323.1M | $322.6M | $344.5M | $304.4M | $159.2M | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$25.0K | -$25.0K | -$25.0K | -$23.0K | -$31.0K | $6.0K | |
| Accruedreturnsreserve | $19.0M | $19.1M | $14.2M | $11.2M | $4.0M | $2.9M | |
| Accrued Liabilities Current | $33.2M | $27.7M | $23.5M | $36.8M | $49.1M | $15.9M | |
| Accounts Payable Current | $3.1M | $2.3M | $11.6M | $4.6M | $8.9M | $3.1M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $39.3M | $4.1M | -$54.6M | $59.0M | $29.7M | ||
| Intangible Assets Net Excluding Goodwill | $88.1M | $98.9M | $109.8M | $120.6M | $131.5M | $0.00 | |
| Goodwill | $22.9M | $22.9M | $22.9M | $22.9M | $22.9M | $0.00 | |
| Gains Losses On Extinguishment Of Debt | $0.00 | $0.00 | -$2.8M | -$1.2M | $0.00 | -$443.0K | |
| Accounts Receivable Net Current | $51.1M | $40.4M | $39.2M | $30.8M | $17.5M | $6.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$861.0K | -$19.3M | -$35.1M | -$28.3M | -$19.3M | -$9.2M | $3.9M | $13.6M | $30.0M | $55.0M | $73.9M | $96.5M | -$2.5M | $19.9M | $44.4M | $14.3M | $24.4M | $27.1M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $95.6M | $63.4M | $62.6M | $63.4M | $61.8M | $66.9M | $50.6M | $50.6M | $55.3M | $84.1M | $95.3M | $103.8M | $59.5M | $63.6M | $66.6M | |||
| Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | $0.00 | $0.00 | $0.00 | -$420.0K | -$601.0K | -$3.4M | -$932.0K | -$781.0K | -$1.4M | -$118.0K | $4.9M | $2.8M | $0.00 | $0.00 | $0.00 | |||
| Cash And Cash Equivalents At Carrying Value | $91.6M | $59.3M | $58.4M | $59.2M | $57.6M | $62.7M | $46.1M | $46.2M | $51.0M | $84.1M | $95.3M | $103.8M | $59.5M | $37.9M | ||||
| Accretion Amortization Of Discounts And Premiums Investments | $0.00 | $184.0K | $382.0K | -$50.0K | -$154.0K | |||||||||||||
| Retained Earnings Accumulated Deficit | -$682.4M | -$683.0M | -$681.1M | -$666.7M | -$651.0M | -$636.0M | -$603.6M | -$591.4M | -$571.6M | -$541.8M | -$520.0M | -$493.8M | -$409.3M | |||||
| Property Plant And Equipment Net | $4.9M | $5.3M | $5.3M | $5.6M | $5.8M | $5.8M | $6.2M | $6.6M | $6.5M | $5.8M | $6.2M | $6.3M | $6.7M | |||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Other Liabilities Noncurrent | $3.4M | $7.8M | $4.8M | $8.5M | $7.7M | $6.1M | $3.7M | $2.7M | $31.0K | $311.0K | $848.0K | $214.0K | $1.9M | |||||
| Other Liabilities Current | $2.6M | $1.6M | $156.0K | $678.0K | $997.0K | $801.0K | $1.1M | $1.7M | $2.8M | $337.0K | $916.0K | $619.0K | $95.0K | |||||
| Other Assets Noncurrent | $5.3M | $5.1M | $5.1M | $5.4M | $5.5M | $4.6M | $4.8M | $4.8M | $4.7M | $2.2M | $2.4M | $2.2M | $211.0K | |||||
| Liabilities Current | $116.2M | $95.2M | $95.1M | $91.0M | $75.5M | $73.1M | $87.0M | $79.7M | $81.4M | $68.6M | $64.5M | $66.5M | $37.3M | |||||
| Liabilities And Stockholders Equity | $370.2M | $334.7M | $315.5M | $321.1M | $331.7M | $336.6M | $327.8M | $328.8M | $321.4M | $303.0M | $318.6M | $337.6M | $131.3M | |||||
| Liabilities | $371.1M | $354.0M | $350.6M | $349.4M | $351.0M | $345.8M | $323.9M | $315.1M | $291.3M | $248.0M | $244.7M | $241.2M | $133.7M | |||||
| Inventory Net | $67.5M | $67.3M | $52.7M | $45.1M | $43.0M | $40.9M | $38.1M | $36.5M | $29.0M | $20.1M | $17.9M | $16.9M | $14.2M | |||||
| Common Stock Value | $17.0K | $16.0K | $16.0K | $15.0K | $15.0K | $15.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $7.0K | |||||
| Assets Current | $224.0M | $185.6M | $163.5M | $162.8M | $170.3M | $173.3M | $158.1M | $155.7M | $165.5M | $148.9M | $161.2M | $177.6M | $124.4M | |||||
| Assets | $370.2M | $334.7M | $315.5M | $321.1M | $331.7M | $336.6M | $327.8M | $328.8M | $321.4M | $303.0M | $318.6M | $337.6M | $131.3M | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$25.0K | -$24.0K | -$25.0K | -$16.0K | -$31.0K | -$36.0K | -$50.0K | -$78.0K | -$29.0K | -$37.0K | -$52.0K | -$66.0K | -$26.0K | |||||
| Accruedreturnsreserve | $19.2M | $19.8M | $19.7M | $17.7M | $16.2M | $14.6M | $13.3M | $11.3M | $13.3M | $7.3M | $5.2M | $5.4M | $3.2M | |||||
| Accrued Liabilities Current | $30.4M | $25.0M | $20.1M | $23.5M | $23.5M | $22.4M | $19.1M | $19.4M | $20.1M | $37.7M | $36.9M | $34.4M | $23.0M | |||||
| Accounts Payable Current | $6.5M | $9.5M | $6.4M | $7.5M | $5.8M | $7.1M | $12.1M | $11.6M | $12.0M | $3.9M | $6.6M | $11.1M | $4.3M | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$13.2M | -$4.8M | -$71.0M | $36.5M | $29.0M | |||||||||||||
| Intangible Assets Net Excluding Goodwill | $90.8M | $93.5M | $96.2M | $101.6M | $104.3M | $107.1M | $112.5M | $115.2M | $117.9M | $123.3M | $126.0M | $128.7M | ||||||
| Goodwill | $22.9M | $22.9M | $22.9M | $22.9M | $22.9M | $22.9M | $22.9M | $22.9M | $22.9M | $22.9M | $22.9M | $22.9M | ||||||
| Gains Losses On Extinguishment Of Debt | $0.00 | -$2.8M | $0.00 | $0.00 | -$1.2M | -$1.3M | $0.00 | |||||||||||
| Accounts Receivable Net Current | $53.8M | $53.0M | $46.3M | $41.1M | $42.4M | $37.4M | $46.0M | $30.2M | $30.9M | $27.5M | $25.8M | $23.4M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Shares Paid For Tax Withholding For Share Based Compensation | 2.7M | 1.55B | 815.2M | 231.3K | 141.6K | |
| Cost Of Goods And Service Excluding Depreciation Depletion And Amortization | $42.6M | $36.8M | $28.6M | $22.6M | $13.3M | $9.3M |
| Share Based Compensation | $22.4M | $18.4M | $10.7M | $12.2M | $11.4M | $8.3M |
| Proceeds From Sale Maturity And Collections Of Investments | $0.00 | $40.2M | $40.0M | $35.0M | $103.6M | $74.7M |
| Payments To Acquire Investments | $0.00 | $34.5M | $43.7M | $0.00 | $43.0M | $101.8M |
| Payments Related To Tax Withholding For Share Based Compensation | $10.9M | $3.7M | $1.0M | $468.0K | $534.0K | $63.0K |
| Net Cash Provided By Used In Operating Activities | $28.6M | -$37.0M | -$47.0M | -$102.9M | -$95.5M | -$80.6M |
| Net Cash Provided By Used In Investing Activities | -$696.0K | $4.9M | -$6.0M | $34.5M | $98.0M | -$27.4M |
| Net Cash Provided By Used In Financing Activities | $11.4M | $36.2M | -$1.6M | $127.5M | $27.2M | $126.1M |
| Increase Decrease In Prepaid Expense | $2.1M | $1.7M | -$3.2M | $3.9M | -$3.3M | -$925.0K |
| Increase Decrease In Other Operating Liabilities | $3.7M | -$1.1M | $3.4M | $2.5M | -$1.2M | $3.2M |
| Increase Decrease In Inventories | $19.3M | $8.8M | $14.8M | $7.5M | $7.4M | $5.1M |
| Increase Decrease In Accrued Liabilities | $3.3M | $3.7M | -$5.9M | -$11.4M | $12.6M | -$2.2M |
| Increase Decrease In Accounts Receivable | $10.6M | $1.2M | $8.4M | $13.4M | $6.2M | $2.2M |
| Increase Decrease In Accounts Payable | -$69.0K | -$9.6M | $7.0M | -$4.3M | $5.5M | -$2.5M |
| Depreciation Depletion And Amortization | $1.3M | $1.2M | $1.5M | $1.4M | $1.3M | $1.5M |
| Proceeds From Stock Options Exercised | $11.6M | $489.0K | $32.0K | $8.0K | $193.0K | $135.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Paid For Tax Withholding For Share Based Compensation | 93.7K | 170.4K | 2.3M | 38.9K | 23.2K | 1.4M | 28.0M | 13.5M | 743.7K | 19.0M | 1.3M | 197.3K | 71.8K | ||
| Cost Of Goods And Service Excluding Depreciation Depletion And Amortization | $11.0M | $11.9M | $8.7M | $13.6M | $7.8M | $6.0M | $8.2M | $7.6M | $5.3M | $5.3M | $4.8M | $6.3M | $3.2M | $3.4M | $1.8M |
| Share Based Compensation | $4.4M | $3.8M | $2.6M | $3.3M | $2.5M | ||||||||||
| Proceeds From Sale Maturity And Collections Of Investments | $0.00 | $5.0M | $0.00 | $6.7M | $34.7M | ||||||||||
| Payments To Acquire Investments | $0.00 | $24.5M | $43.7M | $0.00 | $7.9M | ||||||||||
| Payments Related To Tax Withholding For Share Based Compensation | $8.0M | $3.4M | $863.0K | $416.0K | $365.0K | ||||||||||
| Net Cash Provided By Used In Operating Activities | -$10.0M | -$20.3M | -$26.1M | -$48.4M | -$24.0M | ||||||||||
| Net Cash Provided By Used In Investing Activities | -$13.0K | -$19.7M | -$44.0M | $6.7M | $26.3M | ||||||||||
| Net Cash Provided By Used In Financing Activities | -$3.1M | $35.2M | -$863.0K | $78.2M | $26.7M | ||||||||||
| Increase Decrease In Prepaid Expense | -$1.5M | $1.9M | $1.2M | $58.0K | $15.0K | ||||||||||
| Increase Decrease In Other Operating Liabilities | $1.4M | $800.0K | $99.0K | -$2.7M | -$1.5M | ||||||||||
| Increase Decrease In Inventories | $3.6M | $2.3M | $3.8M | $157.0K | $3.5M | ||||||||||
| Increase Decrease In Accrued Liabilities | -$8.6M | -$1.1M | -$13.9M | -$13.7M | -$2.8M | ||||||||||
| Increase Decrease In Accounts Receivable | $5.9M | -$1.8M | $30.0K | $5.9M | $2.1M | ||||||||||
| Increase Decrease In Accounts Payable | $4.1M | -$4.5M | $6.9M | $2.2M | $1.7M | ||||||||||
| Depreciation Depletion And Amortization | $315.0K | $326.0K | $364.0K | $321.0K | $337.0K | ||||||||||
| Proceeds From Stock Options Exercised | $4.9M | $459.0K | $0.00 | $8.0K | $26.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | $0.00 | -$0.37 | -$0.45 | -$0.70 | -$1.55 | -$2.14 |
| Weighted Average Number Of Diluted Shares Outstanding | 172.7M | 146.8M | 137.7M | 135.6M | 79.0M | |
| Earnings Per Share Basic | $0.00 | $-0.37 | $-0.45 | $-0.70 | $-1.55 | |
| Weighted Average Number Of Shares Outstanding Basic | 160.4M | 146.8M | 137.7M | 135.6M | 79.0M | |
| Common Stock Shares Issued | 166.2M | 149.4M | 138.1M | 136.3M | 124.9M | 59.6M |
| Preferred Stock Shares Authorized | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 10.0M |
| Common Stock Shares Authorized | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 150.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $0.00 | -$0.01 | -$0.06 | -$0.11 | -$0.10 | -$0.14 | -$0.09 | -$0.14 | -$0.12 | -$0.16 | -$0.19 | -$0.25 | -$0.39 | -$0.41 | -$0.30 | -$0.35 | |
| Weighted Average Number Of Diluted Shares Outstanding | 177.6M | 159.5M | 152.4M | 149.0M | 148.3M | 140.5M | 138.1M | 137.3M | 137.1M | 136.0M | 135.5M | 135.0M | 66.5M | 66.4M | 61.2M | ||
| Earnings Per Share Basic | $0.00 | $-0.01 | $-0.06 | $-0.11 | $-0.10 | $-0.14 | $-0.09 | $-0.14 | $-0.12 | $-0.16 | $-0.19 | $-0.25 | $-0.39 | $-0.41 | $-0.30 | ||
| Weighted Average Number Of Shares Outstanding Basic | 163.6M | 159.5M | 152.4M | 149.0M | 148.3M | 140.5M | 138.1M | 137.3M | 137.1M | 136.0M | 135.5M | 135.0M | 66.5M | 66.4M | 61.2M | ||
| Common Stock Shares Issued | 165.5M | 161.2M | 156.0M | 149.0M | 148.9M | 148.2M | 138.1M | 138.0M | 137.3M | 136.0M | 135.9M | 135.5M | 66.5M | 6.6M | |||
| Preferred Stock Shares Authorized | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 10.0M | ||||
| Common Stock Shares Authorized | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 150.0M | ||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $16.2M | $18.2M | $10.7M | $12.2M | $11.4M | $8.3M |
| Interest Income Other | $4.7M | $5.3M | $4.8M | $2.6M | $313.0K | $3.0M |
| Income Loss Attributable To Parent | $554.0K | -$57.1M | -$63.5M | -$96.1M | -$122.7M | -$91.3M |
| Fair Value Adjustment Of Warrants | $0.00 | -$8.0K | -$1.0K | -$1.8M | $702.0K | $9.0K |
| Stock Issued During Period Value Vesting Of Restricted Stock Units | $10.9M | $3.7M | $1.0M | $468.0K | $534.0K | $63.0K |
| Operating Costs And Expenses | $266.9M | $236.7M | $207.9M | $192.2M | $164.7M | $104.0M |
| Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options | $11.6M | $489.0K | $32.0K | $8.0K | $199.0K | $172.0K |
| Amortization Of Financing Costs | $3.4M | $3.0M | $2.2M | $1.6M | $961.0K | $980.0K |
| Interest Paid Net | $27.1M | $26.9M | $27.7M | $10.9M | $7.3M | $4.6M |
| Prepaid Expense Current | $9.5M | $7.5M | $5.8M | $9.3M | $4.6M | $3.2M |
| Increaseinaccruedreturnsreserve | $4.9M | $3.0M | $7.2M | $1.1M | $932.0K | |
| Additional Paid In Capital | $685.0M | $642.3M | $610.3M | $600.0M | $555.4M | $371.1M |
| Accrual For Rebates And Trade Discounts | $43.3M | $29.1M | $22.1M | $16.8M | $15.0M | $6.0M |
| Proceeds Payments From Capital Expenditures | -$696.0K | -$868.0K | -$2.3M | -$524.0K | -$1.1M | |
| Adjustment For Change In Fair Value Of Contingent Value Rights | $0.00 | -$4.4M | -$5.2M | $3.2M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $4.0M | $4.7M | $3.6M | $6.8M | $4.2M | $3.8M | $2.5M | $2.9M | $2.6M | $2.9M | $3.2M | $3.3M | $3.7M | $2.5M | $2.5M | $59.0K | $2.1M | $2.0M |
| Interest Income Other | $1.2M | $948.0K | $1.2M | $1.2M | $1.3M | $1.9M | $1.1M | $1.2M | $1.3M | $472.0K | $195.0K | $68.0K | $66.0K | $77.0K | $100.0K | $232.0K | ||
| Income Loss Attributable To Parent | $621.0K | -$1.9M | -$9.2M | -$19.1M | -$14.3M | -$18.7M | -$12.5M | -$20.5M | -$16.8M | -$22.2M | -$26.5M | -$34.1M | -$26.0M | -$27.5M | -$18.4M | -$16.0M | ||
| Fair Value Adjustment Of Warrants | $0.00 | $0.00 | $0.00 | $0.00 | -$3.0K | -$4.0K | -$17.0K | $14.0K | $0.00 | -$9.0K | -$516.0K | -$1.2M | -$81.0K | $10.0K | -$20.0K | $160.0K | ||
| Stock Issued During Period Value Vesting Of Restricted Stock Units | $478.0K | $859.0K | $8.0M | $82.0K | $51.0K | $3.4M | $72.0K | $25.0K | $863.0K | $28.0K | $0.00 | $416.0K | $365.0K | |||||
| Operating Costs And Expenses | $67.6M | $67.1M | $63.2M | $67.2M | $56.3M | $54.9M | $53.2M | $54.0M | $46.5M | $48.5M | $44.2M | $51.1M | $35.4M | $34.7M | $24.9M | |||
| Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options | $5.2M | $1.2M | $5.0M | -$15.7M | $459.0K | -$12.2M | $32.0K | -$21.8M | -$3.0K | $8.0K | $1.0K | $140.0K | $32.0K | $72.0K | $10.0K | |||
| Amortization Of Financing Costs | $800.0K | $800.0K | $844.0K | $800.0K | $800.0K | $573.0K | $600.0K | $600.0K | $548.0K | $400.0K | $500.0K | $219.0K | $251.0K | |||||
| Interest Paid Net | $0.00 | $1.5M | $9.8M | $3.8M | $2.2M | |||||||||||||
| Prepaid Expense Current | $11.2M | $6.0M | $6.0M | $7.1M | $7.4M | $7.6M | $8.0M | $8.3M | $10.5M | $7.8M | $6.0M | $5.1M | $3.6M | |||||
| Increaseinaccruedreturnsreserve | $622.0K | $395.0K | $2.1M | $1.4M | -$270.0K | |||||||||||||
| Additional Paid In Capital | $681.5M | $663.7M | $646.0M | $638.4M | $631.7M | $626.8M | $607.5M | $605.2M | $601.7M | $596.9M | $594.0M | $590.3M | $406.9M | |||||
| Accrual For Rebates And Trade Discounts | $51.3M | $33.2M | $30.7M | $20.5M | $23.3M | $22.6M | $21.6M | $17.0M | $16.9M | $19.3M | $14.8M | $15.0M | $6.8M | |||||
| Proceeds Payments From Capital Expenditures | -$13.0K | -$164.0K | -$238.0K | $16.0K | -$429.0K | |||||||||||||
| Adjustment For Change In Fair Value Of Contingent Value Rights | $0.00 | -$3.4M | -$1.4M | $2.8M | $0.00 |
Most recent annual filing with the SEC: March 2, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.